医学
达比加群
胃肠病学
内科学
维生素K拮抗剂
门静脉血栓形成
血栓形成
肝硬化
外科
华法林
心房颤动
作者
Madhumita Premkumar,Harish Bhujade,Prerna Sharma,Jasvinder Nain,Jasmina Ahluwalia,Anchal Sandhu,Yogendra Kumar,Sahaj Rathi,Sunil Taneja,Ajay Duseja,Anand V. Kulkarni,Charanpreet Singh,Shano Naseem,Tanka Karki,Pankaj Gupta,Sreedhara B. Chaluvashetty,Deepesh Lad,K. Rajender Reddy
摘要
On dabigatran, 47% of 119 patients achieved portal vein recanalization over 32 months of follow-up which was higher than the spontaneous RR (21.4%) in an untreated cohort. High Factor VIII:Ag was a predictor of non-recanalization. Dabigatran was safe in cirrhosis (CP-A and B) while further work is needed in CP-C.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
fantasy
奋斗易真
不潮薯饼
小小牛马
Nole
14and15
Zephyrite
斯文的初蝶
无极微光
潇洒的惋清
Zzzz
Kao
Copyright
OK
斯文钢笔
老胡
失眠的觅翠
Miya
MchemG
皖公网安备34019202002308
